According to Runcie C.W. Chidebe, a cancer advocate, and executive director of Project PINK BLUE, countries in North Africa have an extensive number of PET-CT scanners and a well-developed nuclear ...

Installed this past fall and used by its first patient in December 2024, the Sanford Joe Lueken Cancer Center boasts a new ...

The Omni Legend PET/CT system, the first of its kind in Western Canada, is already making an impact by reducing wait times and allowing patients to start treatment sooner.

Imagion Biosystems has initiated manufacturing of its MagSense imaging agent for its phase II clinical study on HER2+ breast ...

Siemens Healthineers reaffirms its commitment to enhancing healthcare services and accessibility in Egypt Cairo, Egypt – ...

PET/CT is an imaging study that helps physicians diagnose and treat a variety of conditions, including cancers.

the NeuSight PET-CT supports a wide range of molecular imaging applications, including heart, tumor, and brain studies, showcasing its versatility and commitment to advancing medical diagnostics.

GU ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Glenn Bauman discussing a prospective provincial registry of PSMA PET/CT for recurrent prostate cancer. While most ...

UK MHRA grants marketing authorization to Telix’s prostate cancer PET imaging agent, Illuccix: Melbourne, Australia Friday, February 14, 2025, 10:00 Hrs [IST] Telix, a commercia ...